August 13, 2026

BioPharmGuyNews.png

Isogenica's synthetic humanised VHH libraries for antibody discovery are among the most diverse available. They’re built to reach targets conventional approaches miss like intracellular and hard to reach antigens. 25+ years, 100+ early discovery programmes delivered, candidates in clinical trials. See how the libraries work: https://isogenica.com/synthetic-vhh-libraries/

BioPharmGuy

Why are there so many TV shows these days that are nothing but nonstop stress? Even shows that start out as great comedies seem to devolve into anxiety springs as quickly as season 2. Why are people watching stress-inducing television so frequently? Don't you want to chill out when you watch something in the evening??


-BPG


July Funding

Last month we tracked $2.0B in funding at 38 private companies plus three IPOs for $511M.


Biggest Rounds:

$400M - Chai Discovery

$315M - AdvanCell


Cutest Rounds:

£0.75M - Revolver Therapeutics

$1M - Artan Bio


Full file of funding is available on our downloads page.


Companies Added & Removed

This week we added 21 companies and removed 24.


Best New Name:

AcroCyte Therapeutics


Worst New Name:

Amerging Biotechnolgies


They Will Be Missed:

Ix Therapeutics


This week's update is available free on our downloads page. Check it out and if you like what you see, consider subscribing to our Weekly Update for as little as $10/wk.

Industry

Cash Machine

Everyone always knew solving obesity with a pharmaceutical product was going to be a cash cow.


As it stands, 11% of adults in America are taking GLP1s and 15% have tried it at some point. Considering 41% of US adults were obese prior to the GLP1 craze, there is plenty of room for growth. 


How high will the numbers climb as oral small molecule GLP1s become available? The sky is the limit.


Dethroning statins as the #1 drug class seems inevitable, especially since GLP1s tend to reduce cholesterol levels.


Spokesman Prime

When a celebrity endorses a medical product, they often are actual patients/users.


Deion Sanders had a stomach cancer surgery done with a robotic assist on the Da Vinci surgery platform and is now a spokesman.


We wonder, are these celebs choosing medical procedures and therapies to maximize sponsorship income? Would they admit it if that was true? Is there anything wrong with that?


Maybe not, but feels weird.


Line Go Up, and Down

A publicly traded company felt like they had to address why their stock price doubled, then halved a day later. They stated they were "Unaware of a material change" that would have led to that.


Funny. That kinda makes it sound like they’re saying, “but Maaaaaybe there's a reason and we just don't know it”


Catchy Phrase

Can't blame Chrome's autotranslate for this gem, as it's pulled directly from an image:


"KyungDong Pharmaceutical company hopes for your lifelong health and happiness and endeavor to be a leader to healthier life"


We couldn't have said it better ourselves.


Team Roast - Float On

We would normally say a floating low-res, cropped head of the CEO is a strange choice.


And yet, our life is better for AmacaThera having made that choice, so was it strangeor is it a great choice?


Now that everything is so easy to create, is bad good? What is real? Why are we here?


Sorry got lost there. Point is, it's the floating head of a scowling CEO and it looks pretty weird.

Health & Science

Frankenphage

In an entirely unsurprising revelation, generative AI has been used to help create bacteriophages, which are viruses that exclusively infect bacteria.


More specifically, what happened was scientists tweaked the genome of a known bacteriophage based on what AI suggested. Of 300 attempts, 16 made viable results which is not a terrible success rate.


The general public may think this is a watershed moment, but it is not. People were already doing this. AI may make the work more efficient, but it’s not teaching humans how to do it.


There probably isn’t enough human knowledge of complex biological systems to feed into AI for it to come close to doing this autonomously.


In a positive side of this viral creation story, bacteriophages have been used as therapies for a long time and been viewed as an important weapon against bacteria in the face of antibiotic resistance. If phages can be designed on demand for certain infectious diseases, it could revolutionize human health.


Since it does have that potentially positive use, it will probably get banned in short order.


If only it could be more like crypto and have only downsides, it would surely stay 100% legal.


Shady Peptides

As if the onslaught of shady peptide companies asking to be included in the BioPharmGuy directory wasn’t enough, now we have companies who process payments for shady businesses emailing us because they think WE are a peptide company.


#1 – These peptide companies are absolutely NOT selling them for “research” purposes as they state, so we don’t list them in our directory.


#2 – It is absolutely never ending that people contact BioPharmGuy believing we are a biotech, pharma, device, consulting, peptide or some other type of company we list. How dumb are these marketers? Did they also they think the Yellow Pages phone book sold cars or delivered Chinese food back in the day?


#3 – Who knew the peptide business was shackled financially to such a degree there are specialist companies helping them skirt restrictions in taking payments? It’s almost like they’re selling illegal drugs here and could go to prison for it!


But don't worry, the peptide dispensaries...errrr, pharmacies are doing everything on the up and up to make sure you aren't mainlining deadly pathogens. And when they aren't, they might even let you know.


Weirdly, almost immediately after having written all this, we got our first email from a peptide company rescinding their request to be listed in our directory. Not that we were going to add them but we are left to wonder what kind of legal trouble they now find themselves in...


CDC has a Director

For the first time in a year, the CDC has a director. She is an actual doctor, having served in multiple capacities as a physician and Chief Medical Officer in the Coast Guard and Navy.


Will qualifications matter when she answers to non-physician and general kook, Robert Kennedy? Probably not much.


And Another One

There has been a lot of talk over the past few weeks about China eclipsing the US biotech scene. They have plentiful funding and manpower, Chinese academics are returning home, regulations are looser, etc.


Sure, they will slowly keep catching up for a while. Given the sheer quantity of university-trained people in China, obviously their industry could get very big.


But as industries grow, problems start to accrue.


China is of course the source of the original CRISPR baby (and a hefty jail sentence to accompany it) and now seems to be the epicenter of kids dying in gene therapy clinical trials. It happened again last week.


Authoritarian governments are less squeamish about deaths, but even they have limits. Will this signal an inflection point in this explosive biotech growth? We shall see.


American Healthcare

There is much to poke fun at in the American health system. Yes, we have the most cutting-edge treatments, but we also pay the most and it leads to wildly subpar outcomes compared to almost all other wealthy nations. 


Anyone who has dealt with unemployment in America knows that a major risk factor in not having a job is losing health insurance. That also happens to be a major factor in people not starting their own businesses.


The ACA public health exchange helped with that, but too many people remain tied to their jobs not because it's the best use of their skills or time, but because they can't afford to not have health insurance for themselves and their children.


How big of a problem is this though? 


24% of American workers are staying at their current job because of health insurance. In the biopharm industry that leaps to a ridiculous 39%!


(Maybe take that with a grain of salt - there is no way in this weak of a job market almost 40% of people would be interested in willingly leaving their jobs.)


So, 24% of people are sticking with their employer not because of salary, not because of work environment, motivation to achieve, nothing like that. No, they’re staying there because they are SCARED. Talk about absurd.


Wanna Bet?

Kalshi is all fun and games until savants start betting on kids' cancers responding to drug treatments. For every person that makes that bet, another is rooting for children to die.


But it's not gambling, it's investing in dead children. Big difference.


Danderless Beagles

New beagle puppies have been created to be danderless and allergen-free.


CRISPR was expected to cure genetic diseases at scale. Instead, it's being used to promote dog ownership amongst the upper-middle class.


But don't worry, AI will surely be beneficial to EVERYONE!!!!!!!!

ETC.

Happy 50th

Red Baron turns 50, and for everyone's favorite low-end frozen pizza company, what better way to celebrate than to make a ridiculous pie with 50 toppings!


They chopped them up real tiny-like so no one can possibly taste them all, but still a fun stunt.


And this brings us to the great pizza topping robbery scam being conducted across America as we speak.


Pizzas don't cook right if there are too many toppings on them. So, whether you order a pepperoni pizza or an eight-topping pizza, you get the same total quantity of toppings.


So tell us, why are we being charged $1.85 per hand sprinkle motion?


Rise up and fight the per-topping pantriarchy!

Share!

Use this link to share on social platforms: View as Webpage


Subscribe!

If you haven't already, please join our mailing list.

BioPharmGuy is a registered trademark of Wilsonian LLC, Content © 2026 Wilsonian LLC